Dectin-1 recognizes N-glycan structures from tumor cells, such as in B16 lineage, and activates IRF5 (interferon regulatory factor 5) pathway, among others, to activate natural killer cells to effectively eliminate neoplastic cells (Chiba et al., 2014). This evidence concerns the gene IRF5 and neoplasm.